# Kate Therapeutics Inc. — Form D

Kate Therapeutics Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-07. The offering totals $16.0M, of which $16.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-08-07
- Form: D
- Accession: 0002027042-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $16.0M
- Amount sold: $16.0M
- Investors: 1
- Date of first sale: 2021-02-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-520817

## Issuer

- Name: Kate Therapeutics Inc.
- CIK: 0002032702
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 10675 SORRENTO VALLEY ROAD, SUITE 150, SAN DIEGO, CA, 92121
- Phone: 619-614-3609

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Beth Seidenberg, M.D. | Director | SOUTH SAN FRANCISCO, CA |
| Clare Ozawa, Ph.D. | Director | San Diego, CA |
| Kevin Forrest, Ph.D. | Director | San Diego, CA |
| Kevin Forrest, Ph.D. | Executive Officer | San Diego, CA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-08-07](https://search.stillhousedata.com/formd/0002027042-24-000003) | D | $35.0M | $35.0M |
| [2024-08-07](https://search.stillhousedata.com/formd/0002027042-24-000004) | D | $23.4M | $21.8M |

## More

- [CIK 2032702 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2032702&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002027042-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.